Skip to the main content
The Crier

Transitional Drugs 5

Your saved contracts

What the buyer wrote

The provision of drugs that have recently lost exclusivity, namely Aflibercept; Dapagliflozin; Golimumab

Bid for this and lost? There is a short window in which the decision can be questioned.

Awarded to

Mercury Pharmaceuticals Limited£5.6mends (31 Dec 2027)

Details

What the buyer calls it
Transitional Drugs 5
How they are buying
Advertised, open to anyoneAny supplier could bid without being invited first.
Type
goods
Work starts
1 Jan 2026
Work ends
31 Dec 2027
Where
in Wales

Who the buyer named

The buyer published a contact address on this notice. Questions closed on 14 Nov 2025, 10:00 GMT.

samuel.hughes2@wales.nhs.uk